Equilab International

Equilab International is a leading Indonesian Contract Research Organization (CRO) specializing in Bioavailability (BA) and Bioequivalence (BE) studies. Established in 2002 as part of the Dexa Group, the company provides comprehensive clinical research services including protocol design, clinical trial management, bioanalytical analysis, and statistical reporting. It operates a state-of-the-art facility in Jakarta that is compliant with international standards such as Good Clinical Practice (GCP) and Good Laboratory Practice (GLP). Equilab serves both domestic and international pharmaceutical clients, facilitating the regulatory approval process for generic and new drug products. The organization is recognized as the first CRO in Indonesia to receive accreditation for BA/BE studies from the Indonesian National Agency of Drug and Food Control (BPOM).